KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.05%.

  • TherapeuticsMD's Return on Capital Employed rose 1500.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.13% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Return on Capital Employed is 0.05%, which was up 1500.0% from 0.06% recorded in Q2 2025.
  • TherapeuticsMD's Return on Capital Employed's 5-year high stood at 4.47% during Q2 2022, with a 5-year trough of 1.12% in Q3 2021.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.06% (2025), whereas its average is 0.44%.
  • Per our database at Business Quant, TherapeuticsMD's Return on Capital Employed skyrocketed by 53000bps in 2022 and then tumbled by -37800bps in 2023.
  • Over the past 5 years, TherapeuticsMD's Return on Capital Employed (Quarter) stood at 2.21% in 2021, then plummeted by -99bps to 0.02% in 2022, then crashed by -1268bps to 0.21% in 2023, then soared by 40bps to 0.13% in 2024, then skyrocketed by 60bps to 0.05% in 2025.
  • Its Return on Capital Employed was 0.05% in Q3 2025, compared to 0.06% in Q2 2025 and 0.12% in Q1 2025.